Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

590 Articles

Jon C. Ogg | May 22, 2013 at 8:20 AM EDT

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall…

Paul Ausick | May 15, 2013 at 4:04 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Soft, Close with a Flourish

U.S. equity markets opened slightly lower this morning following a number of data releases related to the U.S. economy. Producer…

Jon C. Ogg | May 14, 2013 at 7:50 AM EDT

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…

Paul Ausick | May 7, 2013 at 9:15 AM EDT

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to…

Jon C. Ogg | Apr 11, 2013 at 8:20 AM EDT

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and…

Jon C. Ogg | Mar 27, 2013 at 8:50 AM EDT

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are…

Jon C. Ogg | Mar 14, 2013 at 9:10 AM EDT

Argus Changes Model Equity Income Portfolio Picks (RIG, AMAT, BMY, COP)

Jon OggArgus is truly considered to be independent research firm, so it is not full of the traditional possible conflicts…

Jon C. Ogg | Mar 4, 2013 at 8:45 AM EST

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals…

Douglas A. McIntyre | Mar 4, 2013 at 6:21 AM EST

Media Digest (3/4/2013) Reuters, WSJ, NYT, FT, Bloomberg

President Obama suggests cuts in Social Security and Medicare to end a battle over budget cuts. (Reuters) Bristol-Myers Squibb Co.…

Jon C. Ogg | Mar 2, 2013 at 12:01 PM EST

Eleven Must-Read Weekend Stock Stories for Monday

Jon Ogg24/7 Wall St. has tracked many stocks on the move in the last week. Now it is the weekend…

Jon C. Ogg | Mar 1, 2013 at 3:06 PM EST

Pharma Merger/Buyout Hunt Continues in Biotech, Valuations Under Focus

ThinkstockThe hunt by Big Pharma stocks for smaller drug companies and biotech stocks continues. A report citing “sources” from Dow…

Jon C. Ogg | Feb 8, 2013 at 10:10 AM EST

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited…

Douglas A. McIntyre | Feb 1, 2013 at 6:35 AM EST

Media Digest (2/1/2013) Reuters, WSJ, FT, Bloomberg

thinkstockPMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell Inc. (NASDAQ: DELL)…

Jon C. Ogg | Jan 25, 2013 at 11:11 AM EST

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

Stocks have rallied sharply during January after the last-minute congressional compromise on the fiscal cliff. While the deal was far…

Paul Ausick | Jan 24, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

U.S. equity markets opened mixed this morning with the DJIA and the S&P 500 higher, and the Nasdaq lower, dragged…

1 … 28 29 30 31 32 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Closing Bell for Wednesday on Wall Street: Markets Open Soft, Close with a Flourish

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

Argus Changes Model Equity Income Portfolio Picks (RIG, AMAT, BMY, COP)

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Media Digest (3/4/2013) Reuters, WSJ, NYT, FT, Bloomberg

Eleven Must-Read Weekend Stock Stories for Monday

Pharma Merger/Buyout Hunt Continues in Biotech, Valuations Under Focus

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Media Digest (2/1/2013) Reuters, WSJ, FT, Bloomberg

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Closing Bell for Wednesday on Wall Street: Markets Open Soft, Close with a Flourish

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

Argus Changes Model Equity Income Portfolio Picks (RIG, AMAT, BMY, COP)

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Media Digest (3/4/2013) Reuters, WSJ, NYT, FT, Bloomberg

Eleven Must-Read Weekend Stock Stories for Monday

Pharma Merger/Buyout Hunt Continues in Biotech, Valuations Under Focus

﻿﻿JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Media Digest (2/1/2013) Reuters, WSJ, FT, Bloomberg

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)